TXG – 10x genomics, inc. (US:NASDAQ)
Stock Stats
News
10x Genomics (NASDAQ:TXG) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
10x Genomics (NASDAQ:TXG) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "cautious" rating.
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
10x Genomics (NASDAQ:TXG) was given a new $20.00 price target on by analysts at Morgan Stanley.
10x Genomics (NASDAQ:TXG) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Taich Adam
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Hindson Benjamin J.
Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Saxonov Serge
Form 144 10x Genomics, Inc. Filed by: Hindson Benjamin J.
Form 144 10x Genomics, Inc. Filed by: Saxonov Serge
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.